SEQENS is a global pharmaceutical manufacturing company offering a broad portfolio of generic and custom APIs, intermediates, and specialty ingredients. Founded in 2003, SEQENS is headquartered in Écully, France, and maintains 15 manufacturing sites and nine R&D centers in nine different countries across Europe, North America, and Asia. The company offers process development, scale-up, and ongoing cGMP manufacturing to support the full product life cycle of small molecule APIs. SEQENS also provides services for large molecules, HPAPIs, non-GMP intermediates, controlled substances, and excipients.
